The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Access to Data and Biospecimens, 2018Interplay Between Microtubules, Alpha-synuclein and Inflammation as a Clue to Understanding and Managing Parkinson’s Disease
Study Rationale:
Recent research has linked alpha-synuclein, a sticky protein that clumps in the brains of people with Parkinson’s disease (PD), and microtubules (cell structure supports) in Parkinson... -
Research Grant, 2018The Role of CD163 in Parkinson's Disease
Study Rationale:
Using pre-clinical models of Parkinson' disease (PD), we found CD163-positive macrophages -- immune cells with the CD163 protein on their surface -- to play an active role in... -
Research Grant, 2018Mapping Genetic and Molecular Networks Linked to Parkinson’s Disease
Study Rationale:
This study aims to produce data that will help to understand the molecular processes and networks underlying Parkinson’s disease (PD). In this study, we will use cells from people who... -
Research Grant, 2018A ROCK Inhibitor as a Neuroprotective Therapy for Parkinson's Disease
Study Rationale:
In the past, we demonstrated that using drugs to deactivate Rho-associated protein kinase (ROCK), a protein regulating shape and movement of cells, can protect dopamine-producing... -
Research Grant, 2018Tracking Mobility and Symptoms of Parkinson's Disease with New Wireless Technology
Study Rationale:
As wearable technology -- smartphones and wearable devices with built-in sensors -- became increasingly more common, affordable and effective, its use in the evaluation and treatment... -
Inflammation Biomarkers Program, 2018Using Changes in Immune Cells to Diagnose or Track Parkinson's Disease
Study Rationale:
There are currently no Parkinson's disease (PD) biomarkers -- objective measures of disease -- in clinical use, but several blood biomarkers are being developed. Some of these...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.